Aramark (ARMK) director Bridgette Heller gains 104.1 shares via dividend rights

Rhea-AI Filing Summary

Aramark director Bridgette P. Heller acquired additional share-based units through a non-cash award. On the reported date, she received 104.1 shares of Aramark common stock as a grant tied to dividend equivalent rights on deferred stock units. These dividend equivalent rights accrue in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards. Following this award, her directly held common stock stake reported in this filing increased to 35,741.188 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Heller Bridgette P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	104.1	$0.00	--

Holdings After Transaction: Common Stock — 35,741.188 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heller Bridgette P

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		104.1(1)	A	$0	35,741.188	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Aramark (ARMK) director Bridgette Heller report on this Form 4?

Bridgette P. Heller reported receiving 104.1 Aramark common shares through a non-cash grant. The award reflects dividend equivalent rights credited on deferred stock units, increasing her directly held position disclosed in this filing to 35,741.188 shares of Aramark common stock.

Was the Aramark (ARMK) insider transaction a stock purchase or a grant?

The Aramark transaction was a grant, not an open-market purchase. Bridgette P. Heller acquired 104.1 common shares at a stated price of $0.00 per share, representing dividend equivalent rights accruing on deferred stock units tied to Aramark’s quarterly dividend.

How many Aramark (ARMK) shares did Bridgette Heller hold after this Form 4 transaction?

After the reported grant, Bridgette P. Heller’s directly held Aramark common stock totaled 35,741.188 shares. This amount includes the 104.1 shares received as dividend equivalent rights on deferred stock units that accrue in line with Aramark’s regular quarterly dividend payments.

What are dividend equivalent rights in this Aramark (ARMK) Form 4?

In this filing, dividend equivalent rights are additional share-based amounts credited on deferred stock units when Aramark pays its quarterly dividend. For Bridgette P. Heller, 104.1 common shares were granted as these rights and will vest on the same schedules as the underlying deferred awards.

Does this Aramark (ARMK) Form 4 indicate insider buying or selling?

The Form 4 shows an acquisition via grant, not buying or selling on the market. Bridgette P. Heller received 104.1 Aramark shares as dividend equivalent rights on deferred stock units, with no sale of shares and a reported price of $0.00 per share.